Appendectomy News and Research

RSS

An appendicectomy (or appendectomy) is the surgical removal of the vermiform appendix. This procedure is normally performed as an emergency procedure, when the patient is suffering from acute appendicitis. In the absence of surgical facilities, intravenous antibiotics are used to delay or avoid the onset of sepsis; it is now recognized that many cases will resolve when treated non-operatively. In some cases the appendicitis resolves completely; more often, an inflammatory mass forms around the appendix. This is a relative contraindication to surgery.

High-risk emergency surgery reduces healthy days at home for seniors

Older adults who undergo high-risk emergency general surgery spend significantly fewer days living independently at home after surgery than those undergoing lower-risk procedures, according to a study published in the Journal of the American College of Surgeons (JACS).

14 Jul 2026

Opioid prescribing after pediatric surgery varies widely across hospitals

Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College of Surgeons (JACS).

1 Jul 2026

Bariatric surgery offers greater long-term health protection for seniors than GLP-1 drugs

Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely-used GLP-1 drugs in older adults with obesity and diabetes, according to new real-world analysis study presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

6 May 2026

Bariatric surgery outperforms GLP-1 medications for obesity disease remission

Metabolic and bariatric surgery delivers significantly greater weight loss and higher rates of obesity-related disease remission than glucagon-like peptide-1 receptor agonists (GLP-1s), according to one of the largest and most comprehensive real-world comparisons of the two treatments.

6 May 2026

U.S. bariatric surgery rates drop significantly amid GLP-1 surge

The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery improves outcomes for patients with obesity and chronic kidney disease

Metabolic and bariatric surgery, also known as weight-loss surgery, dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events and death, according to new research presented here today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

GLP-1 use surges as surgery rates drop for severe obesity

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially -- from less than 4,600 prescriptions in 2018 to more than 1.4 million in 2025 -- according to a new real-world analysis presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery costs significantly less than GLP-1 drugs over two years

A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery is costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according to a new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

GLP-1 drugs combined with surgery yield superior weight loss results

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Gut microbiome clues may help spot Parkinson’s disease in its earliest phase

Researchers found that a Parkinson’s disease-related gut microbiome pattern appears not only in people with diagnosed Parkinson’s, but also in some non-manifesting GBA1 variant carriers and a subset of healthy individuals. The findings suggest that gut microbiome changes may help flag people who are closer to Parkinson’s disease development, although longitudinal studies are still needed to confirm predictive value.

21 Apr 2026

Farmers now owe a lot more for health insurance

Last year was a tough one for farmers. Amid falling prices for commodity crops such as corn and soybeans, rising input costs for supplies like fertilizer and seeds, as well as the Trump tariffs and the dismantling of USAID, many farms weren't profitable last year.

22 Jan 2026

What are the benefits of chewing gum beyond oral health?

Chewing gum offers health benefits beyond oral care, enhancing performance and recovery, but research gaps for children and seniors need addressing.

29 Aug 2025

Why young Americans dread turning 26: Health insurance chaos

Amid the challenges of adulthood, one rite of passage is unique to the United States: the need to find your own health insurance by the time you turn 26.

11 Aug 2025

Weight loss surgery leads to significant boost in self esteem

Self-esteem scores more than doubled within one year of weight-loss surgery, according to a new study* presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

19 Jun 2025

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, according to a new head-to-head real-world study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Minor complication rates higher among Black patients after bariatric procedures

Black patients are more likely to experience minor complications after metabolic and bariatric surgery than White patients, according to new study presented today at the American Society for Metabolic and Bariatric Surgery 2025 Annual Scientific Meeting.

17 Jun 2025

Higher BMI linked to increased risk of complications after bariatric surgery

The higher a person's body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI of 50 or more, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Children with complicated appendicitis can safely recover at home after surgery

Almost half of children who require surgery for complicated appendicitis can safely complete their recovery at home, according to a new study.

20 Mar 2025

Antibiotics prove to be a cheaper and effective option for pediatric appendicitis

Using antibiotics alone to treat children with uncomplicated appendicitis is a cost-saving alternative to surgery, according to a study published in the Journal of the American College of Surgeons (JACS).

26 Nov 2024